Europe Cardiovascular Needle Market, Size, Segment and Growth by Forecast Period: (2023-2028)
The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles.

Europe Cardiovascular Needle Market

Market Overview and Dynamics
The cardiovascular needle market in Europe is projected to grow from US$ 24,408.5 thousand in 2021 to US$ 39,261.2 thousand by 2028, registering a CAGR of 7.0% during the forecast period. The increasing prevalence of cardiovascular diseases in developing regions is largely attributed to shifting lifestyles, urbanization, and reduced physical activity due to modernization of residential, commercial, and industrial infrastructures. Additionally, rising stress levels contribute to the growing incidence of heart-related conditions.

📚Download Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00025899

These trends are further supported by the rapid development of healthcare infrastructure and the adoption of advanced technologies in emerging countries. According to the Global Burden of Disease study published in The Lancet, cardiovascular diseases are linked to approximately 10 deaths per 100,000 people, accounting for an estimated 6.4 million deaths globally.

Given these dynamics, emerging markets present lucrative opportunities for cardiovascular needle manufacturers. By offering affordable, high-quality products, companies can tap into these underpenetrated regions and drive significant growth over the forecast period.

Market Introduction

Cardiovascular needles are essential tools used in various cardiac surgeries, including open-heart procedures, heart transplants, cardiac valve surgeries, and coronary artery bypass grafting. These needles are categorized into two main types: single-use (eyeless) and reusable (eyed) needles. They are typically made from advanced stainless-steel alloys such as Surgalloy and Ethalloy, which contain high concentrations of nickel for enhanced performance and durability.

The growing prevalence of cardiovascular diseases is expected to significantly boost the demand for cardiovascular needles in the coming years, thereby driving market growth.

However, the COVID-19 pandemic has had a substantial impact on cardiac surgery across Europe. Many procedures have been postponed or delayed as healthcare systems redirected critical care resources to manage the pandemic. In the UK, for example, data from the British Heart Foundation revealed that approximately 371,000 heart operations and procedures were conducted in 2020—representing a 22% decline from the 473,000 performed in 2019. Notably, surgeries such as coronary bypass and heart valve procedures dropped from 37,000 to around 25,000 cases by the end of November 2020. Similarly, procedures like stent placements to open blocked arteries also saw a decline.

In the United States, research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons reported a 53% nationwide reduction in adult cardiac surgeries due to the pandemic. Furthermore, data from Public Health England indicated over 5,700 excess deaths related to heart diseases and stroke since the onset of COVID-19, with delays in heart surgeries and procedures likely playing a major role in these increased mortality figures.

Europe Cardiovascular Needle Strategic Insights

Strategic insights for the Europe Cardiovascular Needle provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

key company profiles

  Ethicon (Johnson & Johnson Services, Inc.)

  MANI, INC

  Barber of Sheffield

  FSSB surgical needles GmbH

  Medtronic

  Teleflex Incorporated

  Meril Life Sciences Pvt. Ltd.

  CP Medical

  SMB Corporation of India

Europe Cardiovascular Needle Market – Regional Insights
The geographic scope of the Europe cardiovascular needle market encompasses the specific regions where companies operate and compete. Recognizing regional differences—such as consumer preferences, healthcare infrastructure, economic conditions, and regulatory frameworks—is essential for developing market-specific strategies. Tailoring product offerings and approaches to meet the unique demands of each region enables businesses to identify growth opportunities in underserved areas. This targeted focus enhances resource allocation, optimizes marketing efforts, strengthens competitive positioning, and supports sustained market expansion across Europe.

Key Market Segments

  • By Type: The round-bodied needles segment held the largest share of the Europe cardiovascular needle market in 2020.
  • By Application: The open-heart surgery segment dominated the market in 2020.
  • By Usage: Single-use needles accounted for the largest market share in 2020.
  • By End User: Hospitals and clinics were the leading end users in the Europe cardiovascular needle market in 2020.

Key Sources and Companies Referenced
The report draws insights from a variety of primary and secondary sources, including company websites, annual and financial reports, government publications, and statistical databases. Prominent companies featured in the Europe cardiovascular needle market include:

  • Ethicon (Johnson & Johnson Services, Inc.)
  • MANI, INC.
  • Barber of Sheffield
  • FSSB surgical needles GmbH
  • Medtronic
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • CP Medical
  • SMB Corporation of India

Reasons to Purchase This Report

  • Gain a comprehensive understanding of the Europe cardiovascular needle market and identify high-potential segments for strong ROI.
  • Stay competitive by analyzing the evolving market landscape and key players.
  • Strategically plan mergers, acquisitions, and partnerships by targeting the most promising segments.
  • Make well-informed business decisions through detailed segment-level performance insights.
  • Access revenue forecasts for various market segments from 2021 to 2028 within the European region.



About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights


disclaimer

Comments

https://newyorktimesnow.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!